Search

FDA gives thumbs down to Sarepta's next Duchenne's muscular dystrophy drug

FDA GIVES THUMBS DOWN TO SAREPTA'S NEXT DUCHENNE'S MUSCULAR DYSTROPHY DRUG

The decision stood in contrast with the agency's highly controversial approval of Sarepta's previous DMD drug, Exondys 51. The company's...

FDA approves AbbVie rheumatoid arthritis drug

FDA APPROVES ABBVIE RHEUMATOID ARTHRITIS DRUG

Reuters reported that the drug, Rinvoq, will carry a list price of $59,000 per year. AbbVie's top-selling drug, Humira, is also approved...

 
 
 
New antibiotic for drug-resistant tuberculosis scores FDA approval

NEW ANTIBIOTIC FOR DRUG-RESISTANT TUBERCULOSIS SCORES FDA APPROVAL

The drug was developed by the non-profit TB Alliance. Some experts have said nonprofit organizations may provide a long-term solution...

Trump adviser described as ‘key architect' of drug-pricing blueprint to step down

TRUMP ADVISER DESCRIBED AS ‘KEY ARCHITECT' OF DRUG-PRICING BLUEPRINT TO STEP DOWN

John O'Brien, a former insurance industry executive, will step down less than one year after his appointment as senior advisory to...

 
 
 
Amid biopharma's Brexit fears, Johnson hopes to sweeten immigration deal for scientists

AMID BIOPHARMA'S BREXIT FEARS, JOHNSON HOPES TO SWEETEN IMMIGRATION DEAL FOR SCIENTISTS

Aimed at science, engineering and technology specialists, the changes would create a fast-track visa system that would make it easier...

Analysts grill Novartis execs amid gene therapy data manipulation scandal

ANALYSTS GRILL NOVARTIS EXECS AMID GENE THERAPY DATA MANIPULATION SCANDAL

Novartis CEO Vas Narasimhan said the data manipulation issue was confined to a disused potency assay for use in mice and predated the...

 
 
 

NUMBER OF FEMALE BIOTECH CEOS REMAINS ‘SHOCKINGLY LOW,' PUTTING SPOTLIGHT ON BIO | BIOPHARMA DIVE

Female chief executives remain exceedingly rare in the drug industry, accounting for less than 10% of biotech's top leaders - a “shockingly,...

Trump administration proposes allowing some drug importation

TRUMP ADMINISTRATION PROPOSES ALLOWING SOME DRUG IMPORTATION

The administration proposed two pathways, one that would allow importation of some drugs from Canada via pilot projects, and another...

 
 
 
Expert panel to review Nektar drug delayed as FDA postpones opioid meetings

EXPERT PANEL TO REVIEW NEKTAR DRUG DELAYED AS FDA POSTPONES OPIOID MEETINGS

In a regulatory filing, the company said that the postponement was not unique to NKTR-181, though it may result in a delay in the FDA's...

Allergan recalls Biocell breast implants, warns physicians not to use them

ALLERGAN RECALLS BIOCELL BREAST IMPLANTS, WARNS PHYSICIANS NOT TO USE THEM

The company initiated the voluntary recall of textured Biocell breast implants and tissue expanders after it received a warning from...

 
 
 
LunaPBC is trading company shares for member health data

LUNAPBC IS TRADING COMPANY SHARES FOR MEMBER HEALTH DATA

On the company's LunaDNA platform, a whole genome can be exchanged for 300 company shares, while 20 days of fitness data is equal to...

NITTO BIOPHARMA, INC: SR. SCIENTIST, ANALYTICAL R&D NBPI031

Nitto BioPharma, Inc: Reporting To: Associate Director, Analytical R&DCore CompetenciesDemonstrated success conducting independent...

 
 
 

J&J, NOVARTIS HELP MEDICXI RAISE €400M BIOPHARMA FUND

Medicxi has raised a €400 million biopharma investment fund. Johnson & Johnson and Novartis pumped money into the fund as cornerstone...

Kroger partners with Myriad Genetics on genetic testing pilot

KROGER PARTNERS WITH MYRIAD GENETICS ON GENETIC TESTING PILOT

The grocery chain is offering select Kroger Health Plan members access to Myriad's GeneSight test, which analyzes specific genes as...

 
 
 
Reckitt Benckiser to pay federal government $1.4B to resolve investigation into opioid sales

RECKITT BENCKISER TO PAY FEDERAL GOVERNMENT $1.4B TO RESOLVE INVESTIGATION INTO OPIOID SALES

The settlement, reached Thursday, resolves an investigation concerning the opioid addiction treatment Suboxone Film, made by former...

NITTO BIOPHARMA, INC: STAFF SCIENTIST OR SR. SCIENTIST, PHARM R\U0026D NBPI024

Nitto BioPharma, Inc: , Inc.JOB DESCRIPTIONPosition: Staff or Sr. Scientist, Pharm R&DReporting To: Associate Director, Pharm R&DCore...

 
 
 
As precision medicine grows, so does the importance of clinical trial diversity

AS PRECISION MEDICINE GROWS, SO DOES THE IMPORTANCE OF CLINICAL TRIAL DIVERSITY

Experts said the rise of cutting-edge new therapies highlighted disparities between clinical trial populations and the patients receiving...

Ovid Therapeutics starts Phase III trial in rare neurological disorder

OVID THERAPEUTICS STARTS PHASE III TRIAL IN RARE NEUROLOGICAL DISORDER

The trial's primary endpoint will be one for which the drug, OV101, produced encouraging but mixed results in a Phase II study of patients...

 
 
 
FDA turns down approval for Daiichi Sankyo leukemia drug

FDA TURNS DOWN APPROVAL FOR DAIICHI SANKYO LEUKEMIA DRUG

The outcome was not surprising, in light of a negative vote by an FDA expert panel last month, but an investigator in the study criticized...

NITTO BIOPHARMA, INC: RESEARCH ASSOCIATE CODE NBPI020

Nitto BioPharma, Inc: Position: Research Associate job code NBPI020Position ObjectiveThe successful candidate will join our research...